{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:59:36Z","timestamp":1769605176356,"version":"3.49.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["4016906"],"award-info":[{"award-number":["4016906"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["4024727"],"award-info":[{"award-number":["4024727"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021705","name":"\u00dastav Molekul\u00e1rn\u00ed Genetiky, Akademie V\u011bd \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["68378050"],"award-info":[{"award-number":["68378050"]}],"id":[{"id":"10.13039\/501100021705","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"MEYS CR","doi-asserted-by":"crossref","award":["LM2023050"],"award-info":[{"award-number":["LM2023050"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["17-09103S"],"award-info":[{"award-number":["17-09103S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pan European Network in Lipidomics and EpiLipidomics","award":["CA19105 EpiLipidNET"],"award-info":[{"award-number":["CA19105 EpiLipidNET"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11438-1","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T09:57:43Z","timestamp":1768211863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fibrillarin and fibrillarin-like their role in cancer progression: new approaches and perspectives"],"prefix":"10.1007","volume":"53","author":[{"given":"Jaime Abelardo","family":"Ceja-Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jany","family":"Valdes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Miladinovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovica","family":"Antiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Carlos","family":"Rodr\u00edguez-Zapata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Hozak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"11438_CR1","unstructured":"World Health Organization. Cancer [Internet], Geneva WHO (2024) [cited 2025 Mar 15]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer"},{"key":"11438_CR2","unstructured":"World Health Organization [Internet], Ginebra OMS (2025) [cited 2025 Mar 15]. Available from: https:\/\/www.who.int\/es"},{"key":"11438_CR3","unstructured":"Tribastone Trujill LP (2020) Metabolismo de c\u00e9lulas cancerosas"},{"issue":"7","key":"11438_CR4","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.ymthe.2021.03.017","volume":"29","author":"Y Xu","year":"2021","unstructured":"Xu Y, Qiu M, Shen M, Dong S, Ye G, Shi X, Sun M (2021) The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism. Mol Ther 29(7):2209\u20132218. https:\/\/doi.org\/10.1016\/j.ymthe.2021.03.017","journal-title":"Mol Ther"},{"issue":"4","key":"11438_CR5","first-page":"1394","volume":"23","author":"AJ Berm\u00fadez Garcell","year":"2019","unstructured":"Berm\u00fadez Garcell AJ, Serrano G\u00e1mez NB, Teruel Gin\u00e9s R, Leyva Montero MDL\u00c1, Naranjo Coronel AA (2019) Biolog\u00eda Del c\u00e1ncer. Correo Cient\u00edfico M\u00e9dico 23(4):1394\u20131416","journal-title":"Correo Cient\u00edfico M\u00e9dico"},{"key":"11438_CR6","unstructured":"Gonz\u00e1lez Rom\u00e1n M (2023) Factores de transcripci\u00f3n oncog\u00e9nicos \u00bfposibles dianas terap\u00e9uticas en c\u00e1ncer?"},{"issue":"21","key":"11438_CR7","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1007\/s00018-015-1984-1","volume":"72","author":"H Takada","year":"2015","unstructured":"Takada H, Kurisaki A (2015) Emerging roles of nucleolar and ribosomal proteins in cancer, development, and aging. Cell Mol Life Sci 72(21):4015\u20134025. https:\/\/doi.org\/10.1007\/s00018-015-1984-1","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"11438_CR8","doi-asserted-by":"publisher","first-page":"e56230","DOI":"10.15252\/embr.202256230","volume":"24","author":"X Sun","year":"2023","unstructured":"Sun X, Gao C, Xu X, Li M, Zhao X, Wang Y et al (2023) FBL promotes cancer cell resistance to DNA damage and BRCA1 transcription via YBX1. EMBO Rep 24(9):e56230. https:\/\/doi.org\/10.15252\/embr.202256230","journal-title":"EMBO Rep"},{"issue":"6","key":"11438_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/boc.201400077","volume":"107","author":"U Rodriguez-Corona","year":"2015","unstructured":"Rodriguez-Corona U, Sobol M, Rodriguez-Zapata LC, Hozak P, Castano E (2015) Fibrillarin from archaea to human. Biol Cell 107(6):159\u2013174. https:\/\/doi.org\/10.1111\/boc.201400077","journal-title":"Biol Cell"},{"key":"11438_CR10","unstructured":"Rodr\u00edguez Corona U (2018) Estudio funcional de la Fibrilarina como ribonucleasa [Tesis doctoral, Centro de Investigaci\u00f3n Cient\u00edfica de Yucat\u00e1n]"},{"key":"11438_CR11","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1134\/S0006297916090030","volume":"81","author":"MY Shubina","year":"2016","unstructured":"Shubina MY, Musinova YR, Sheval EV (2016) Nucleolar methyltransferase fibrillarin: evolution of structure and functions. Biochem (Moscow) 81:941\u2013950. https:\/\/doi.org\/10.1134\/S0006297916090030","journal-title":"Biochem (Moscow)"},{"issue":"1","key":"11438_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/s12885-022-09552-x","volume":"22","author":"F Van Nguyen","year":"2022","unstructured":"Van Nguyen F, Lardy-Cleaud A, Car\u00e8ne D, Rossoni C, Catez F, Rollet P et al (2022) Low level of fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer. BMC Cancer 22(1):526. https:\/\/doi.org\/10.1186\/s12885-022-09552-x","journal-title":"BMC Cancer"},{"issue":"11","key":"11438_CR13","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/onc.2013.89","volume":"33","author":"H Su","year":"2014","unstructured":"Su H, Xu T, Ganapathy S, Shadfan M, Long M, Huang THM et al (2014) Elevated snorna biogenesis is essential in breast cancer. Oncogene 33(11):1348\u20131358. https:\/\/doi.org\/10.1038\/onc.2013.89","journal-title":"Oncogene"},{"issue":"4","key":"11438_CR14","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.ajpath.2010.12.040","volume":"178","author":"CM Koh","year":"2011","unstructured":"Koh CM, Gurel B, Sutcliffe S, Aryee MJ, Schultz D, Iwata T et al (2011) Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene. Am J Pathol 178(4):1824\u20131834. https:\/\/doi.org\/10.1016\/j.ajpath.2010.12.040","journal-title":"Am J Pathol"},{"issue":"8","key":"11438_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/bioengineering9080396","volume":"9","author":"W Luo","year":"2022","unstructured":"Luo W, Lin S, Huang Y, Zhu K, Zhang F, Lin J et al (2022) Bioinformatic analysis and in vitro and in vivo experiments reveal that fibrillarin participates in the promotion of lung metastasis in hepatocellular carcinoma. Bioengineering 9(8):396. https:\/\/doi.org\/10.3390\/bioengineering9080396","journal-title":"Bioengineering"},{"issue":"9","key":"11438_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41419-023-06165-5","volume":"14","author":"M Wisztorski","year":"2023","unstructured":"Wisztorski M, Aboulouard S, Roussel L, Duhamel M, Saudemont P, Cardon T, Salzet M (2023) Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis. Cell Death Dis 14(9):644","journal-title":"Cell Death Dis"},{"key":"11438_CR17","doi-asserted-by":"publisher","first-page":"1171932","DOI":"10.3389\/fonc.2023.1171932","volume":"13","author":"J Luo","year":"2024","unstructured":"Luo J, Zhu WC, Chen QX, Yang CF, Huang BJ, Zhang SJ (2024) A prognostic model based on DNA methylation-related gene expression for predicting overall survival in hepatocellular carcinoma. Front Oncol 13:1171932","journal-title":"Front Oncol"},{"issue":"2","key":"11438_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3892\/ol.2020.12353","volume":"21","author":"J Zhang","year":"2021","unstructured":"Zhang J, Yang G, Li Q, Xie F (2021) Increased fibrillarin expression is associated with tumor progression and an unfavorable prognosis in hepatocellular carcinoma. Oncol Lett 21(2):92. https:\/\/doi.org\/10.3892\/ol.2020.12353","journal-title":"Oncol Lett"},{"issue":"17","key":"11438_CR19","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1158\/0008-5472.CAN-24-2125","volume":"84","author":"H Luo","year":"2024","unstructured":"Luo H, Kharas MG (2024) Dotting out AML by targeting fibrillarin. Cancer Res 84(17):2759\u20132760","journal-title":"Cancer Res"},{"issue":"33","key":"11438_CR20","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.2174\/0929867326666181203133332","volume":"26","author":"B El Hassouni","year":"2019","unstructured":"El Hassouni B, Sarkisjan D, Vos JC, Giovannetti E, Peters GJ (2019) Targeting the ribosome biogenesis key molecule fibrillarin to avoid chemoresistance. Curr Med Chem 26(33):6020\u20136032. https:\/\/doi.org\/10.2174\/0929867326666181203133332","journal-title":"Curr Med Chem"},{"issue":"4","key":"11438_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41388-024-03207-w","volume":"44","author":"M Wen","year":"2025","unstructured":"Wen M, Qiu Y, Wang M, Tang F, Hu W, Zhu Y, Tan R (2025) Enhancing low-dose radiotherapy efficacy with PARP inhibitors via FBL-mediated oxidative stress response in colorectal cancer. Oncogene 44(4):228\u2013240. https:\/\/doi.org\/10.1038\/s41388-024-03207-w","journal-title":"Oncogene"},{"issue":"48","key":"11438_CR22","doi-asserted-by":"publisher","first-page":"e2406961121","DOI":"10.1073\/pnas.2406961121","volume":"121","author":"D Zhang","year":"2024","unstructured":"Zhang D, Li B, Xu H, Li J, Ma C, Ge W et al (2024) Identification of FBLL1 as a neuron-specific RNA 2\u2032-O-methyltransferase mediating neuronal differentiation. Proc Natl Acad Sci 121(48):e2406961121. https:\/\/doi.org\/10.1073\/pnas.2406961121","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"11438_CR23","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1038\/s41401-022-00901-x","volume":"43","author":"J Yang","year":"2022","unstructured":"Yang J, Miao R, Li Y, Pan T, Wu S, Qu X et al (2022) Atypical chemokine receptor 3 induces colorectal tumorigenesis in mice by promoting \u03b2-arrestin-NOLC1-fibrillarin-dependent rRNA biogenesis. Acta Pharmacol Sin 43(11):2967\u20132976. https:\/\/doi.org\/10.1038\/s41401-022-00901-x","journal-title":"Acta Pharmacol Sin"},{"key":"11438_CR24","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Velasco I, Herrera-Escamilla AK, V\u00e1zquez-Salazar A (2025) Nucleolar origins: challenging perspectives on evolution and function. Open Biology 15(3)","DOI":"10.1098\/rsob.240330"},{"issue":"3","key":"11438_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41419-021-03531-z","volume":"12","author":"SE Weeks","year":"2021","unstructured":"Weeks SE, Kammerud SC, Metge BJ, AlSheikh HA, Schneider DA, Chen D, Samant RS (2021) Inhibiting \u03b2-catenin disables nucleolar functions in triple-negative breast cancer. Cell Death Dis 12(3):242","journal-title":"Cell Death Dis"},{"issue":"4","key":"11438_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/biom8040106","volume":"8","author":"PL Monaco","year":"2018","unstructured":"Monaco PL, Marcel V, Diaz JJ, Catez F (2018) 2\u2032-O-methylation of ribosomal RNA: towards an epitranscriptomic control of translation? Biomolecules 8(4):106","journal-title":"Biomolecules"},{"key":"11438_CR27","doi-asserted-by":"crossref","unstructured":"Erales J, Marchand V, Panthu B, Gillot S, Belin S, Ghayad SE, Diaz JJ (2017) Evidence for rRNA 2\u2032-O-methylation plasticity: Control of intrinsic translational capabilities of human ribosomes. Proceedings of the National Academy of Sciences 114(49):12934\u201312939","DOI":"10.1073\/pnas.1707674114"},{"issue":"3","key":"11438_CR28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccr.2013.08.013","volume":"24","author":"V Marcel","year":"2013","unstructured":"Marcel V, Ghayad SE, Belin S, Therizols G, Morel AP, Solano-Gonz\u00e0lez E, Diaz JJ (2013) p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Cancer Cell 24(3):318\u2013330","journal-title":"Cancer Cell"},{"issue":"1","key":"11438_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ccr.2012.05.019","volume":"22","author":"MJ Bywater","year":"2012","unstructured":"Bywater MJ, Poortinga G, Sanij E, Hein N, Peck A, Cullinane C, Hannan RD (2012) Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell 22(1):51\u201365","journal-title":"Cancer Cell"},{"key":"11438_CR30","doi-asserted-by":"crossref","unstructured":"Sun X, Gao C, Xu X, Li M, Zhao X, Wang Y, Wu C (2023) FBL promotes cancer cell resistance to DNA damage and BRCA1 transcription via YBX1. EMBO Rep 24(9):e56230","DOI":"10.15252\/embr.202256230"},{"issue":"13","key":"11438_CR31","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1134\/S0006297911130049","volume":"76","author":"IA Eliseeva","year":"2011","unstructured":"Eliseeva IA, Kim ER, Guryanov SG, Ovchinnikov LP, Lyabin DN (2011) Y-box-binding protein 1 (YB-1) and its functions. Biochem (Moscow) 76(13):1402\u20131433","journal-title":"Biochem (Moscow)"},{"issue":"5","key":"11438_CR32","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/cas.14006","volume":"110","author":"M Kuwano","year":"2019","unstructured":"Kuwano M, Shibata T, Watari K, Ono M (2019) Oncogenic Y-box binding protein\u20101 as an effective therapeutic target in drug\u2010resistant cancer. Cancer Sci 110(5):1536\u20131543","journal-title":"Cancer Sci"},{"key":"11438_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.biochi.2020.10.004","volume":"179","author":"F Sangermano","year":"2020","unstructured":"Sangermano F, Delicato A, Calabr\u00f2 V (2020) Y box binding protein 1 (YB-1) oncoprotein at the hub of DNA proliferation, damage and cancer progression. Biochimie 179:205\u2013216","journal-title":"Biochimie"},{"issue":"1","key":"11438_CR34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/wrna.1200","volume":"5","author":"DN Lyabin","year":"2014","unstructured":"Lyabin DN, Eliseeva IA, Ovchinnikov LP (2014) YB-1 protein: functions and regulation. Wiley Interdisciplinary Reviews: RNA 5(1):95\u2013110","journal-title":"Wiley Interdisciplinary Reviews: RNA"},{"issue":"3","key":"11438_CR35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s42764-021-00042-1","volume":"2","author":"Y Liu","year":"2021","unstructured":"Liu Y, Lu LY (2021) BRCA1: a key player at multiple stages of homologous recombination in DNA double-strand break repair. Genome Instability Disease 2(3):164\u2013174","journal-title":"Genome Instability Disease"},{"issue":"3","key":"11438_CR36","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cell.2017.06.034","volume":"170","author":"A Canela","year":"2017","unstructured":"Canela A, Maman Y, Jung S, Wong N, Callen E, Day A, Nussenzweig A (2017) Genome organization drives chromosome fragility. Cell 170(3):507\u2013521","journal-title":"Cell"},{"issue":"4","key":"11438_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s42764-020-00017-8","volume":"1","author":"Y Katsuki","year":"2020","unstructured":"Katsuki Y, Jeggo PA, Uchihara Y, Takata M, Shibata A (2020) DNA double-strand break end resection: A critical relay point for determining the pathway of repair and signaling. Genome Instability Disease 1(4):155\u2013171","journal-title":"Genome Instability Disease"},{"issue":"12","key":"11438_CR38","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1631\/jzus.B2300518","volume":"24","author":"Y Mu","year":"2023","unstructured":"Mu Y, Han J, Wu M, Li Z, Du K, Wei Y, Huang J (2023) Fibrillarin promotes homologous recombination repair by facilitating the recruitment of recombinase RAD51 to DNA damage sites. J Zhejiang University-SCIENCE B 24(12):1165\u20131173","journal-title":"J Zhejiang University-SCIENCE B"},{"issue":"6330","key":"11438_CR39","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1126\/science.aam7344","volume":"355","author":"CJ Lord","year":"2017","unstructured":"Lord CJ, Ashworth A (2017) PARP inhibitors: synthetic lethality in the clinic. Science 355(6330):1152\u20131158","journal-title":"Science"},{"issue":"4","key":"11438_CR40","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41388-024-03207-w","volume":"44","author":"M Wen","year":"2025","unstructured":"Wen M, Qiu Y, Wang M, Tang F, Hu W, Zhu Y, Tan R (2025) Enhancing low-dose radiotherapy efficacy with PARP inhibitors via FBL-mediated oxidative stress response in colorectal cancer. Oncogene 44(4):228\u2013240","journal-title":"Oncogene"},{"issue":"1","key":"11438_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-020-00927-w","volume":"13","author":"H Qin","year":"2020","unstructured":"Qin H, Ni H, Liu Y, Yuan Y, Xi T, Li X et al (2020) RNA-binding proteins in tumor progression. J Hematol Oncol 13(1):90","journal-title":"J Hematol Oncol"},{"issue":"6","key":"11438_CR42","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jcmgh.2023.02.004","volume":"15","author":"CS Kam","year":"2023","unstructured":"Kam CS, Ho DWH, Ming VSI, Tian L, Sze KMF, Zhang VX et al (2023) PFKFB4 drives oncogenicity in TP53-mutated hepatocellular carcinoma in a phosphatase-dependent manner. Cell Mol Gastroenterol Hepatol 15(6):1325\u20131350","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"11438_CR43","doi-asserted-by":"publisher","first-page":"217190","DOI":"10.1016\/j.canlet.2024.217190","volume":"602","author":"Y Liu","year":"2024","unstructured":"Liu Y, Shi Q, Liu Y, Li X, Wang Z, Huang S et al (2024) Fibrillarin reprograms glucose metabolism by driving the enhancer-mediated transcription of PFKFB4 in liver cancer. Cancer Lett 602:217190","journal-title":"Cancer Lett"},{"issue":"4","key":"11438_CR44","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3390\/cancers13040909","volume":"13","author":"K Kotowski","year":"2021","unstructured":"Kotowski K, Rosik J, Machaj F, Supplitt S, Wiczew D, Jab\u0142o\u0144ska K et al (2021) Role of PFKFB3 and PFKFB4 in cancer: genetic basis, impact on disease development\/progression, and potential as therapeutic targets. Cancers 13(4):909","journal-title":"Cancers"},{"issue":"3","key":"11438_CR45","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.cell.2016.07.012","volume":"166","author":"B Deplancke","year":"2016","unstructured":"Deplancke B, Alpern D, Gardeux V (2016) The genetics of transcription factor DNA binding variation. Cell 166(3):538\u2013554","journal-title":"Cell"},{"issue":"1","key":"11438_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s10020-020-00252-5","volume":"26","author":"L Wang","year":"2020","unstructured":"Wang L, Zhou N, Qu J, Jiang M, Zhang X (2020) Identification of an RNA binding protein-related gene signature in hepatocellular carcinoma patients. Mol Med 26(1):125","journal-title":"Mol Med"},{"issue":"48","key":"11438_CR47","doi-asserted-by":"publisher","first-page":"e2406961121","DOI":"10.1073\/pnas.2406961121","volume":"121","author":"D Zhang","year":"2024","unstructured":"Zhang D, Li B, Xu H, Li J, Ma C, Ge W et al (2024) Identification of FBLL1 as a neuron-specific RNA 2\u2032-O-methyltransferase mediating neuronal differentiation. Proc Natl Acad Sci 121(48):e2406961121","journal-title":"Proc Natl Acad Sci"},{"key":"11438_CR48","doi-asserted-by":"publisher","unstructured":"Goodacre A (2023) Investigations into the role of RNA modification in the function of the c-Myc IRES [Apollo - University. https:\/\/doi.org\/10.17863\/CAM.107483. of Cambridge Repository]","DOI":"10.17863\/CAM.107483"},{"key":"11438_CR49","doi-asserted-by":"publisher","unstructured":"Xie JW, Tang YH, Wang YH et al Construction and verification of a prognostic model for prostate cancer based on ribosome Biogenesis-Related Genes, 23 June 2025, PREPRINT (Version 1) available at Research Square https:\/\/doi.org\/10.21203\/rs.3.rs-6830289\/v1","DOI":"10.21203\/rs.3.rs-6830289\/v1"},{"issue":"2","key":"11438_CR50","first-page":"1536","volume":"5","author":"Y Chen","year":"2025","unstructured":"Chen Y (2025) Ribosome biogenesis related genes as prognostic genes in glioma: A study based on transcriptomics and Mendelian randomization. Curr Sci 5(2):1536\u20131558","journal-title":"Curr Sci"},{"issue":"4","key":"11438_CR51","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.ajpath.2010.12.040","volume":"178","author":"CM Koh","year":"2011","unstructured":"Koh CM, Gurel B, Sutcliffe S, Aryee MJ, Schultz D, Iwata T, De Marzo AM (2011) Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene. Am J Pathol 178(4):1824\u20131834","journal-title":"Am J Pathol"},{"issue":"24","key":"11438_CR52","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1016\/j.molcel.2024.11.028","volume":"84","author":"J Hu","year":"2024","unstructured":"Hu J, Li D, Liu C (2024) LncRNAs chaperoning dynamic protein condensates in cancer cells. Mol Cell 84(24):4695\u20134697","journal-title":"Mol Cell"},{"issue":"11","key":"11438_CR53","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1038\/s41401-022-00901-x","volume":"43","author":"J Yang","year":"2022","unstructured":"Yang J, Miao R, Li Y, Pan T, Wu S, Qu X et al (2022) Atypical chemokine receptor 3 induces colorectal tumorigenesis in mice by promoting \u03b2-arrestin-NOLC1-fibrillarin-dependent rRNA biogenesis. Acta Pharmacol Sin 43(11):2967\u20132976","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"11438_CR54","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1016\/j.celrep.2018.11.051","volume":"25","author":"A Iyer-Bierhoff","year":"2018","unstructured":"Iyer-Bierhoff A, Krogh N, Tessarz P, Ruppert T, Nielsen H, Grummt I (2018) SIRT7-dependent deacetylation of fibrillarin controls histone H2A methylation and rRNA synthesis during the cell cycle. Cell Rep 25(11):2946\u20132954e5","journal-title":"Cell Rep"},{"issue":"7484","key":"11438_CR55","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature12819","volume":"505","author":"P Tessarz","year":"2014","unstructured":"Tessarz P, Santos-Rosa H, Robson SC, Sylvestersen KB, Nelson CJ, Nielsen ML et al (2014) Glutamine methylation in histone H2A is an RNA-polymerase-I-dedicated modification. Nature 505(7484):564\u2013568","journal-title":"Nature"},{"key":"11438_CR56","doi-asserted-by":"crossref","unstructured":"Zimmerman MW, Homanics GE, Lazo JS (2013) Targeted deletion of the metastasis-associated phosphatase Ptp4a3 (PRL-3) suppresses murine colon cancer. PLoS ONE 8(3):e58300","DOI":"10.1371\/journal.pone.0058300"},{"issue":"21","key":"11438_CR57","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1242\/jcs.123661","volume":"126","author":"S Yildirim","year":"2013","unstructured":"Yildirim S, Casta\u00f1o E, Sobol M, Philimonenko VV, Dzijak R, Venit T et al (2013) Involvement of PIP2 in RNA polymerase I transcription. J Cell Sci 126(21):4978\u20134987. https:\/\/doi.org\/10.1242\/jcs.123661","journal-title":"J Cell Sci"},{"issue":"1","key":"11438_CR58","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/s41467-018-04072-4","volume":"9","author":"D Li","year":"2018","unstructured":"Li D, Zhang J, Wang M, Li X, Gong H, Tang H et al (2018) Activity-dependent LoNA regulates translation by coordinating rRNA transcription and methylation. Nat Commun 9(1):1726","journal-title":"Nat Commun"},{"issue":"1","key":"11438_CR59","doi-asserted-by":"publisher","first-page":"27583","DOI":"10.1038\/s41598-024-77500-9","volume":"14","author":"S Qian","year":"2024","unstructured":"Qian S, Liu H, Zhang M, Zhang L, Dai Y, Ye X et al (2024) Pan-cancer landscape analysis of NOP58 and its oncogenic driving role in lung adenocarcinoma. Sci Rep 14(1):27583","journal-title":"Sci Rep"},{"issue":"2","key":"11438_CR60","doi-asserted-by":"publisher","first-page":"101387","DOI":"10.1016\/j.gendis.2024.101387","volume":"12","author":"S Yang","year":"2025","unstructured":"Yang S, Liu J, Luo S, Wang W, Xu J (2025) NOP56 promotes hepatocellular carcinoma progression through 2\u2032-O-methylation. Genes Dis 12(2):101387","journal-title":"Genes Dis"},{"issue":"9","key":"11438_CR61","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3390\/cells13090781","volume":"13","author":"T Zhao","year":"2024","unstructured":"Zhao T, Fan J, Abu-Zaid A, Burley SK, Zheng XS (2024) Nuclear mTOR signaling orchestrates transcriptional programs underlying cellular growth and metabolism. Cells 13(9):781","journal-title":"Cells"},{"issue":"2","key":"11438_CR62","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1128\/MCB.19.2.1301","volume":"19","author":"MK Abe","year":"1999","unstructured":"Abe MK, Kuo WL, Hershenson MB, Rosner MR (1999) Extracellular signal-regulated kinase 7 (ERK7), a novel ERK with a C-terminal domain that regulates its activity, its cellular localization, and cell growth. Mol Cell Biol 19(2):1301\u20131312","journal-title":"Mol Cell Biol"},{"key":"11438_CR63","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fcell.2016.00056","volume":"4","author":"KM Reyskens","year":"2016","unstructured":"Reyskens KM, Arthur JSC (2016) Emerging roles of the mitogen and stress activated kinases MSK1 and MSK2. Front Cell Dev Biology 4:56","journal-title":"Front Cell Dev Biology"},{"key":"11438_CR64","doi-asserted-by":"publisher","first-page":"e50796","DOI":"10.7554\/eLife.50796","volume":"8","author":"CC Yang","year":"2019","unstructured":"Yang CC, Kato H, Shindo M, Masai H (2019) Cdc7 activates replication checkpoint by phosphorylating the Chk1-binding domain of Claspin in human cells. Elife 8:e50796","journal-title":"Elife"},{"key":"11438_CR65","doi-asserted-by":"crossref","unstructured":"Geanes ES, McLennan R, Pierce SH, Menden HL, Paul O, Sampath V, Bradley T (2024) SARS-CoV-2 envelope protein regulates innate immune tolerance. Iscience 27(6)","DOI":"10.1016\/j.isci.2024.109975"},{"key":"11438_CR66","doi-asserted-by":"crossref","unstructured":"Gronkowska K, Robaszkiewicz A (2024) Genetic dysregulation of EP300 in cancers in light of cancer epigenome control\u2013targeting of p300-proficient and-deficient cancers. Mol Therapy Oncol 32(4)","DOI":"10.1016\/j.omton.2024.200871"},{"issue":"7","key":"11438_CR67","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.3390\/ijms26073101","volume":"26","author":"S Yang","year":"2025","unstructured":"Yang S, Manna C, Manna PR (2025) Harnessing the role of ESR1 in breast cancer: correlation with microRNA, lncRNA, and methylation. Int J Mol Sci 26(7):3101","journal-title":"Int J Mol Sci"},{"issue":"7","key":"11438_CR68","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.3390\/ijms23073735","volume":"23","author":"J Kiezun","year":"2022","unstructured":"Kiezun J, Godlewski J, Krazinski BE, Kozielec Z, Kmiec Z (2022) Galanin receptors (GalR1, GalR2, and GalR3) expression in colorectal cancer tissue and correlations to the overall survival and poor prognosis of CRC patients. Int J Mol Sci 23(7):3735","journal-title":"Int J Mol Sci"},{"issue":"4","key":"11438_CR69","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41419-024-06656-z","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang Y, Song S, Li S, Kang J, Li Y, Zhao N, Wu H (2024) GATA4 regulates the transcription of MMP9 to suppress the invasion and migration of breast cancer cells via HDAC1-mediated p65 deacetylation. Cell Death Dis 15(4):289","journal-title":"Cell Death Dis"},{"issue":"1","key":"11438_CR70","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/s41467-019-09295-7","volume":"10","author":"L Gao","year":"2019","unstructured":"Gao L, Hu Y, Tian Y, Fan Z, Wang K, Li H, Chen L (2019) Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 Inhibition. Nat Commun 10(1):1665","journal-title":"Nat Commun"},{"issue":"12","key":"11438_CR71","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.3390\/biomedicines11123194","volume":"11","author":"YQ Guo","year":"2023","unstructured":"Guo YQ, Gan MF, Bao JQ, Zhou HX, Yang J, Dai CJ, Zheng JM (2023) KDF1 promoted Proliferation, migration and invasion of lung adenocarcinoma cells through activating STAT3 and AKT pathway. Biomedicines 11(12):3194","journal-title":"Biomedicines"},{"issue":"2","key":"11438_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijo.2025.5718","volume":"66","author":"N He","year":"2025","unstructured":"He N, Yang Q, Li Z, Guo J, Kuang C, Zhu Y, Zhou W (2025) LGR4 promotes proliferation and homing via activation of the NF \u03baB signaling pathway in multiple myeloma. Int J Oncol 66(2):1\u201316","journal-title":"Int J Oncol"},{"issue":"1","key":"11438_CR73","doi-asserted-by":"publisher","first-page":"127","DOI":"10.21873\/invivo.13419","volume":"38","author":"Y Deng","year":"2024","unstructured":"Deng Y, Ke TW, Yueh TC, Chin YT, Wang YC, Hung YC, Tsai CW (2024) The contribution of DNA ligase 4 polymorphisms to colorectal cancer. Vivo 38(1):127\u2013133","journal-title":"Vivo"},{"key":"11438_CR74","doi-asserted-by":"publisher","first-page":"1527309","DOI":"10.3389\/fcell.2025.1527309","volume":"13","author":"S Zhang","year":"2025","unstructured":"Zhang S, Zhang Y, Feng S, Han M, Wang Z, Qiao D, Zhong J (2025) Tumor-promoting effect and tumor immunity of SRSFs. Front Cell Dev Biology 13:1527309","journal-title":"Front Cell Dev Biology"},{"issue":"48","key":"11438_CR75","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1038\/s41388-022-02509-1","volume":"41","author":"M Ma","year":"2022","unstructured":"Ma M, Zhang C, Cao R, Tang D, Sang X, Zou S, Fu X (2022) UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination. Oncogene 41(48):5199\u20135213","journal-title":"Oncogene"},{"issue":"17","key":"11438_CR76","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.3390\/cancers16173064","volume":"16","author":"B Maffeo","year":"2024","unstructured":"Maffeo B, Cilloni D (2024) The ubiquitin-conjugating enzyme E2 O (UBE2O) and its therapeutic potential in human leukemias and solid tumors. Cancers 16(17):3064","journal-title":"Cancers"},{"key":"11438_CR77","doi-asserted-by":"crossref","unstructured":"Wang L, Wang J, Wang N, Wang X, Song M, Zhou Y, Miao S (2025) ANLN promotes head and neck squamous cell carcinoma progression by upregulating PD-L1 via the ERK-MAPK pathway. iScience 28(2)","DOI":"10.1016\/j.isci.2024.111633"},{"issue":"7","key":"11438_CR78","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/s41416-024-02584-z","volume":"130","author":"ET Shah","year":"2024","unstructured":"Shah ET, Molloy C, Gough M, Kryza T, Samuel SG, Tucker A, Adams MN (2024) Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells. Br J Cancer 130(7):1196\u20131205","journal-title":"Br J Cancer"},{"issue":"1","key":"11438_CR79","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41419-025-07404-7","volume":"16","author":"M Zhang","year":"2025","unstructured":"Zhang M, Bai J, Yuan H, Duan X, Yu L, Li Y, Wang C (2025) BRD1 deficiency affects SREBF1-related lipid metabolism through regulating H3K9ac\/H3K9me3 transition to inhibit HCC progression. Cell Death Dis 16(1):104","journal-title":"Cell Death Dis"},{"issue":"1","key":"11438_CR80","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s12672-025-02421-6","volume":"16","author":"S Tao","year":"2025","unstructured":"Tao S, Yang Y (2025) Pyroptosis drives tumor progression and immune evasion in hepatocellular carcinoma: a single-cell and Spatial transcriptomic study. Discover Oncol 16(1):834","journal-title":"Discover Oncol"},{"issue":"1","key":"11438_CR81","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12672-025-01986-6","volume":"16","author":"C Xu","year":"2025","unstructured":"Xu C, Liu M, Li Y, Peng X, Zhou W, Zhang W, Yu B (2025) The role and mechanism of CHMP4C in poor prognosis and drug sensitivity of lung adenocarcinoma. Discover Oncol 16(1):270","journal-title":"Discover Oncol"},{"issue":"24","key":"11438_CR82","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1158\/0008-5472.CAN-23-0883","volume":"83","author":"C Rawat","year":"2023","unstructured":"Rawat C, Ben-Salem S, Singh N, Chauhan G, Rabljenovic A, Vaghela V, Heemers HV (2023) Prostate cancer progression relies on the mitotic kinase Citron kinase. Cancer Res 83(24):4142\u20134160","journal-title":"Cancer Res"},{"key":"11438_CR83","doi-asserted-by":"crossref","unstructured":"Luo AL, Zheng WY, Zhang Q, Yuan Y, Li MQ, Du K, Deng M (2025) COPS5 triggers ferroptosis defense by stabilizing MK2 in hepatocellular carcinoma. Adv Sci 2416360","DOI":"10.1002\/advs.202416360"},{"key":"11438_CR84","unstructured":"Hee-Joo C, Tuan NM, Hwan KS, Jaehee K, Jeong-Yeon L, Kyung PM (2025) DOT1L as a therapeutic target. Insights into Epigenetic Regulation and Cancer Treatment"},{"key":"11438_CR85","doi-asserted-by":"crossref","unstructured":"Cao S, Wang L, Song G (2025) Computational Identification of Ect2 as a Potential Pan-Cancer Biomarker and Therapeutic Target Through Integrated Genomic Data Analysis. Available at SSRN 4913884","DOI":"10.21203\/rs.3.rs-5687415\/v1"},{"issue":"1","key":"11438_CR86","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12894-025-01732-8","volume":"25","author":"J Wang","year":"2025","unstructured":"Wang J, Lai X, Sun Z, Feng S, Li B, Zhao H (2025) KIF14 plays a role in the regulation of the cell cycle and has implications for prognosis in clear cell renal cell carcinoma. BMC Urol 25(1):74","journal-title":"BMC Urol"},{"issue":"17","key":"11438_CR87","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.3390\/cancers16172958","volume":"16","author":"DO Moon","year":"2024","unstructured":"Moon DO (2024) Advancing cancer therapy: the role of KIF20A as a target for inhibitor development and immunotherapy. Cancers 16(17):2958","journal-title":"Cancers"},{"issue":"24","key":"11438_CR88","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1002\/1873-3468.15004","volume":"598","author":"S Cotino-N\u00e1jera","year":"2024","unstructured":"Cotino-N\u00e1jera S, Garc\u00eda\u2010Villa E, Cruz\u2010Rosales S, Gariglio P, D\u00edaz\u2010Ch\u00e1vez J (2024) The role of Lin28A and Lin28B in cancer beyond Let\u20107. FEBS Lett 598(24):2963\u20132979","journal-title":"FEBS Lett"},{"issue":"10","key":"11438_CR89","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.3390\/cancers15102683","volume":"15","author":"K Nejati-Koshki","year":"2023","unstructured":"Nejati-Koshki K, Roberts CT, Babaei G, Rastegar M (2023) The epigenetic reader methyl-CpG-binding protein 2 (MeCP2) is an emerging oncogene in cancer biology. Cancers 15(10):2683","journal-title":"Cancers"},{"issue":"7","key":"11438_CR90","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1158\/2767-9764.CRC-22-0522","volume":"3","author":"S Duan","year":"2023","unstructured":"Duan S, Sheriff S, Elvis-Offiah UB, Witten BL, Sawyer TW, Sundaresan S, Merchant JL (2023) Clinically defined mutations in MEN1 alter its tumor-suppressive function through increased Menin turnover. Cancer Res Commun 3(7):1318\u20131334","journal-title":"Cancer Res Commun"},{"issue":"4","key":"11438_CR91","doi-asserted-by":"publisher","first-page":"ar40","DOI":"10.1091\/mbc.E24-12-0542","volume":"36","author":"A Kifer","year":"2025","unstructured":"Kifer A, Pina F, Codallos N, Hermann A, Ziegler L, Niwa M (2025) Orchestration of SARS-CoV-2 Nsp4 and host cell ESCRT proteins induces morphological changes of the Endoplasmic reticulum. Mol Biol Cell 36(4):ar40","journal-title":"Mol Biol Cell"},{"issue":"5","key":"11438_CR92","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/biom14050541","volume":"14","author":"G Mansueto","year":"2024","unstructured":"Mansueto G, Fusco G, Colonna G (2024) A tiny viral Protein, SARS-CoV-2-ORF7b: functional molecular mechanisms. Biomolecules 14(5):541","journal-title":"Biomolecules"},{"issue":"2","key":"11438_CR93","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/cells14020069","volume":"14","author":"AB Awan","year":"2025","unstructured":"Awan AB, Osman MJA, Khan OM (2025) Ubiquitination enzymes in cancer, cancer immune Evasion, and potential therapeutic opportunities. Cells 14(2):69","journal-title":"Cells"},{"issue":"19","key":"11438_CR94","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.3390\/cancers16193310","volume":"16","author":"H Lee","year":"2024","unstructured":"Lee H, Bae AN, Yang H, Lee JH, Park JH (2024) Modulation of PRC1 promotes anticancer effects in pancreatic cancer. Cancers 16(19):3310","journal-title":"Cancers"},{"key":"11438_CR95","doi-asserted-by":"publisher","first-page":"1229507","DOI":"10.3389\/fonc.2023.1229507","volume":"13","author":"R Sharma","year":"2023","unstructured":"Sharma R, Oak N, Chen W, Gogal R, Kirschner M, Beier F, Wlodarski M (2023) Germline landscape of RPA1, RPA2 and RPA3 variants in pediatric malignancies: identification of RPA1 as a novel cancer predisposition candidate gene. Front Oncol 13:1229507","journal-title":"Front Oncol"},{"issue":"5","key":"11438_CR96","doi-asserted-by":"publisher","first-page":"80","DOI":"10.14715\/cmb\/2023.69.5.14","volume":"69","author":"L Liang","year":"2023","unstructured":"Liang L, Zhao Z, Jin Q, Zhang S, Zhao Z, Li X (2023) RPA3 promotes the proliferation, migration, and invasion of gliomas by activating the PI3K-AKT-mTOR pathway. Cell Mol Biol 69(5):80\u201386","journal-title":"Cell Mol Biol"},{"issue":"1","key":"11438_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-025-15159-9","volume":"25","author":"M Azami","year":"2025","unstructured":"Azami M, Sadeghi F, Mohammadi N, Shayegh ZS, Hassanzadeh A, Heidarzadeh MJ, Mohamadi Z (2025) Clinical and mechanistic insights into the expression of SP100 family proteins in various cancers: a systematic review. BMC Cancer 25(1):1\u201326","journal-title":"BMC Cancer"},{"key":"11438_CR98","doi-asserted-by":"publisher","first-page":"155831","DOI":"10.1016\/j.cyto.2022.155831","volume":"153","author":"W Chen","year":"2022","unstructured":"Chen W, Zhang Y, Fang Z, Qi W, Xu Y (2022) TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-\u03b2\/SMAD pathway. Cytokine 153:155831","journal-title":"Cytokine"},{"issue":"7","key":"11438_CR99","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.7150\/jca.92723","volume":"15","author":"J Jiang","year":"2024","unstructured":"Jiang J, Dong X, Liu J, Liu T, Chen X, Bian X, Liu Y (2024) TRIM67 promotes non-small cell lung cancer development by positively regulating the Notch pathway through DLK1 ubiquitination. J Cancer 15(7):1870","journal-title":"J Cancer"},{"key":"11438_CR100","doi-asserted-by":"crossref","unstructured":"Leask A, Nguyen J, Naik A, Chitturi P, Riser BL (2024) The role of yes activated protein (YAP) in melanoma metastasis. Iscience 27(6)","DOI":"10.1016\/j.isci.2024.109864"},{"key":"11438_CR101","doi-asserted-by":"crossref","unstructured":"Tanu T, Cox AM, Karlow J, Sharma P, He X, Wu C, Insco ML (2025) Recurrent oncogenic ZC3H18 mutations stabilize endogenous retroviral RNA","DOI":"10.1101\/2025.01.10.632423"},{"key":"11438_CR102","doi-asserted-by":"publisher","first-page":"110200","DOI":"10.1016\/j.cellsig.2021.110200","volume":"90","author":"D Miao","year":"2022","unstructured":"Miao D, Wang Y, Jia Y, Tong J, Jiang S, Liu L (2022) ZRANB1 enhances stem-cell-like features and accelerates tumor progression by regulating Sox9-mediated USP22\/Wnt\/\u03b2-catenin pathway in colorectal cancer. Cell Signal 90:110200","journal-title":"Cell Signal"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11438-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11438-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11438-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:35:54Z","timestamp":1768473354000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11438-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11438"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11438-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with any animals or human.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval and consent to participate"}}],"article-number":"275"}}